Lipidomics provides new biomarkers for cardiovascular disease and Type 2 diabetes

The lipid metabolism plays an important role in the development of cardiovascular diseases and Type 2 diabetes. However, little is known about the molecular relationships. Using lipidomics, a modern analytical method, the team led by Dr. Fabian Eichelmann from DIfE and DZD identified those lipids that are statistically associated with cardiovascular disease and Type 2 diabetes. In addition, the scientists found that a diet with an increased proportion of unsaturated fatty acids (FAs) leads to a reduction in risk-associated lipids and an increase in low-risk lipids. The findings were published in the journal Circulation.
The lipid metabolism plays an important role in the development of cardiovascular diseases and Type 2 diabetes. However, little is known about the molecular relationships. Using lipidomics, a modern analytical method, the team led by Dr. Fabian Eichelmann from DIfE and DZD identified those lipids that are statistically associated with cardiovascular disease and Type 2 diabetes. In addition, the scientists found that a diet with an increased proportion of unsaturated fatty acids (FAs) leads to a reduction in risk-associated lipids and an increase in low-risk lipids. The findings were published in the journal Circulation.